Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 7/20 | 0.44 |
| ▸ | CES2 | O00748 | 6/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28458216 | 0.80 | CES1 (0.41) | CES1CES2ALDH1A1MAPTHPGD | |
| SCHEMBL1671010 | 0.78 | NAAA (0.47) | CES1CES2NAAAALDH1A1MAPT | |
| SCHEMBL10704887 | 0.77 | ALDH1A1 (0.35) | CES1CES2ALDH1A1 | |
| SCHEMBL10516214 | 0.75 | CES1 (0.43) | CES1CES2NAAAALDH1A1MAPT | |
| SCHEMBL28163593 | 0.74 | CES1 (0.50) | CES1CES2NAAAALDH1A1LMNA | |
| SCHEMBL27317630 | 0.74 | CES1 (0.44) | CES1CES2NAAAALDH1A1MAPT | |
| SCHEMBL15261109 | 0.73 | CES1 (0.49) | CES1CES2NAAAALDH1A1LMNA | |
| SCHEMBL5321540 | 0.73 | CES1 (0.49) | CES1CES2NAAAALDH1A1LMNA | |
| SCHEMBL6932937 | 0.73 | GAA (0.50) | CES1CES2NAAAALDH1A1MAPT | |
| SCHEMBL26064181 | 0.73 | CES1 (0.49) | CES1CES2NAAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109053482-A | A kind of preparation method of N- (4- aminobenzoyl)-Pidolidone | 上海雅本化学有限公司 | 2018-12-21 | — | — | CN | disclosed |